Martin Welschof of Opsona Therapeutics
joined us for World Orphan Drug Congress USA 2015 to present about '
Sending the Right Signals to the Immune System'.
Download the presentation now to understand more about:
The value of targeting TLRs
Opsona's lead compound OPN-305
Efficacy: convincing data in pre-clinical studies
OPN-305 Overall Clinical Development Strategy
Get your copy here!
To find out more about
Opsona Therapeutics and OPN-305
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (1,550Kb in size)